BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kayaaslan B, Guner R. Adverse effects of oral antiviral therapy in chronic hepatitis B. World J Hepatol 2017; 9(5): 227-241 [PMID: 28261380 DOI: 10.4254/wjh.v9.i5.227]
URL: https://www.wjgnet.com/1007-9327/full/v9/i5/227.htm
Number Citing Articles
1
Chun-Ru Cheng, Uwem O. Edet, Innocent Benjamin, Chinyere U. Okoro, Wilfred Emori, Elizabeth N. Mbim, Obinna C. Godfrey, Francisca O. Nwaokorie, Jenavine O. Mbah, Richard U. Ukpanukpong, Amanda-Lee E. Manicum, Hitler Louis. Effect of solvation on the molecular structure, vibrational assignment, nature of bonding, and the antiviral drug-like potential of troxerutin against HBV proteinsJournal of the Indian Chemical Society 2023; 100(6): 100994 doi: 10.1016/j.jics.2023.100994
2
Raquel Scherer de Fraga, Victor Van Vaisberg, Luiz Cláudio Alfaia Mendes, Flair José Carrilho, Suzane Kioko Ono. Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic reviewJournal of Gastroenterology 2020; 55(5): 496 doi: 10.1007/s00535-020-01680-0
3
Monisha Simon, Ameena Meah. Tenofovir as a cause of acquired fanconi's syndromeAnnals of African Medicine 2023; 22(1): 128 doi: 10.4103/aam.aam_198_21
4
Lukasz T. Olenginski, Solomon K. Attionu, Erica N. Henninger, Regan M. LeBlanc, Andrew P. Longhini, Theodore K. Dayie. Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic TargetViruses 2023; 15(9): 1913 doi: 10.3390/v15091913
5
Mojisola Ogunnaike, Srijanee Das, Samiksha S. Raut, Ashrafi Sultana, Mohammad Ullah Nayan, Murali Ganesan, Benson J. Edagwa, Natalia A. Osna, Larisa Y. Poluektova. Chronic Hepatitis B Infection: New Approaches towards CureBiomolecules 2023; 13(8): 1208 doi: 10.3390/biom13081208
6
Bijayata Patra, Poulomi Ghosh, Saprativ P. Das. Model Organisms to Study Biological Activities and Toxicity of Nanoparticles2020; : 195 doi: 10.1007/978-981-15-1702-0_10
7
William W. L. Wong, Petros Pechivanoglou, Josephine Wong, Joanna M. Bielecki, Alex Haines, Aysegul Erman, Yasmin Saeed, Arcturus Phoon, Mina Tadrous, Mona Younis, Noha Z. Rayad, Valeria Rac, Harry L. A. Janssen, Murray D. Krahn. Antiviral treatment for treatment-naïve chronic hepatitis B: systematic review and network meta-analysis of randomized controlled trialsSystematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-1126-1
8
Yutaka Tsukune, Makoto Sasaki, Norio Komatsu. Reactivation of Hepatitis B Virus in Patients with Multiple MyelomaCancers 2019; 11(11): 1819 doi: 10.3390/cancers11111819
9
Luca Soraci, Antonio Cherubini, Luca Paoletti, Gianfranco Filippelli, Filippo Luciani, Pasqualina Laganà, Maria Elsa Gambuzza, Elvira Filicetti, Andrea Corsonello, Fabrizia Lattanzio. Safety and Tolerability of Antimicrobial Agents in the Older PatientDrugs & Aging 2023; 40(6): 499 doi: 10.1007/s40266-023-01019-3
10
Heejoon Jang, Su Jong Yu, Hong Ghi Lee, Tae Min Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim. Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized StudyJournal of Korean Medical Science 2023; 38(28) doi: 10.3346/jkms.2023.38.e216
11
Takayuki Fujii, Kei‐ichiro Takase, Hiroyuki Honda, Nobutoshi Kawamura, Ryo Yamasaki, Michiyo Urata, Takeshi Uchiumi, Toru Iwaki, Jun‐ichi Kira. Toxic myopathy with multiple deletions in mitochondrial DNA associated with long‐term use of oral anti‐viral drugs for hepatitis B: A case studyNeuropathology 2019; 39(2): 162 doi: 10.1111/neup.12548
12
Alessandra M. de A. Maciel, Maria Lucia C. G. Ferraz, Renata de M. Perez, Carlos Eduardo Brandão-Mello. Renal dysfunction during treatment of chronic hepatitis B with tenofovir disoproxyl fumarate and associated risk factorsEuropean Journal of Gastroenterology & Hepatology 2024; 36(4): 482 doi: 10.1097/MEG.0000000000002723
13
Su‐Shen Lim, Hsien‐Tzung Liao, Chang‐Youh Tsai. Telbivudine associated mitochondrial myopathyLiver International 2018; 38(6): 1139 doi: 10.1111/liv.13742
14
Soon Sun Kim, Eun Kyoung Ahn, Soo Yeon Cho, Rae Woong Park, Hyo Jung Cho, Ji-Hyun Kim, Han Gyeol Kim, Ga Ram Lee, Sun Hyuk Hwang, Min Jae Yang, Jae Youn Cheong, Sung Won Cho. Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis BMedicine 2018; 97(24): e11087 doi: 10.1097/MD.0000000000011087
15
Vishal S. Patil, Darasaguppe R. Harish, Umashankar Vetrivel, Sanjay H. Deshpande, Pukar Khanal, Harsha V. Hegde, Subarna Roy, Sunil S. Jalalpure. Pharmacoinformatics Analysis Reveals Flavonoids and Diterpenoids from Andrographis paniculata and Thespesia populnea to Target Hepatocellular Carcinoma Induced by Hepatitis B VirusApplied Sciences 2022; 12(21): 10691 doi: 10.3390/app122110691
16
Nese Inan, Fehmi Tabak. Viral Hepatitis: Chronic Hepatitis B2018; : 71 doi: 10.1007/978-3-319-93449-5_7
17
Nikki Ledoux. Hepatitis B and Acute Liver FailureCritical Care Nursing Clinics of North America 2022; 34(3): 259 doi: 10.1016/j.cnc.2022.04.012
18
I. Vern Lim, Nurgül Özgür Yurttaş, Mesut Ayer, Şule Poturoğlu, Erdem Kınacı, İlgin Özden. Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamideClinical Case Reports 2023; 11(8) doi: 10.1002/ccr3.7741
19
Sreekumar Othumpangat, John D. Noti. A Worldwide Yearly Survey of New Data in Adverse Drug ReactionsSide Effects of Drugs Annual 2018; 40: 345 doi: 10.1016/bs.seda.2018.08.005
20
Nicholas Zareifopoulos, Maria Lagadinou, Anastasia Karela, Ourania Kyriakopoulou, Dimitrios Velissaris. Neuropsychiatric Effects of Antiviral DrugsCureus 2020;  doi: 10.7759/cureus.9536
21
In Suk Min, Chang Hun Lee, Ik Sang Shin, Na Eun Lee, Hong Seon Son, Seung Bum Kim, Seung Young Seo, Seong Hun Kim, Sang Wook Kim, Seung Ok Lee, Soo Teik Lee, In Hee Kim. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration RateGut and Liver 2019; 13(1): 93 doi: 10.5009/gnl18183
22
Beyza Dönmüş, Sinan Ünal, Fatma Ceren Kirmizitaş, Nelisa Türkoğlu Laçin. Virus-associated ribozymes and nano carriers against COVID-19Artificial Cells, Nanomedicine, and Biotechnology 2021; 49(1): 204 doi: 10.1080/21691401.2021.1890103
23
Xiao Lin, Aixin Song, Sujun Zheng, Xinyue Chen. Respiratory failure as the prominent manifestation of entecavir-associated mitochondrial myopathy: a case reportBMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07159-y
24
Robério Amorim de Almeida Pondé, Guilherme de Sousa Pondé Amorim. Elimination of the hepatitis B virus: A goal, a challengeMedicinal Research Reviews 2024;  doi: 10.1002/med.22030
25
Suman Pilli, Peck Lin Lip. Reversible retinal toxicity in early oral Entecavir therapy for hepatitis-B infectionEye 2018; 32(11): 1792 doi: 10.1038/s41433-018-0156-6
26
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
27
Burcu ÖNDER, Fatih Oğuz ÖNDER, Betül YAVUZ KELEŞ. Antiviral Use-Related Femoral Neuropathy: A Case Report Femoral NeuropathyAcibadem Universitesi Saglik Bilimleri Dergisi 2020; 12(1): 156 doi: 10.31067/acusaglik.831303
28
Zhouqi Tang, Tengfang Li, Helong Dai, Chen Feng, Xubiao Xie, Fenghua Peng, Gongbin Lan, Shaojie Yu, Yu Wang, Chunhua Fang, Manhua Nie, Xiaoqiong Yuan, Xiaotian Tang, Xin Jiang, Xuejing Zhu, Yuxi Fan, Jiawei Peng, Siyu Sun, Mingda Zhong, Hedong Zhang, Longkai Peng. Drug-induced Fanconi syndrome in patients with kidney allograft transplantationFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.979983
29
Rob Bielen, Geert Robaeys, Sigrid Schelfhout, Diethard Monbaliu, Schalk Van der Merwe, Jacques Pirenne, Frederik Nevens. Personalized subcutaneous administration of hepatitis B surface antibodies without nucleos(t)ide analogs for patients at risk of renal failure after liver transplantation: a prospective single center cohort studyTransplant International 2018; 31(5): 503 doi: 10.1111/tri.13112
30
Jirayu Kammarabutr, Panupong Mahalapbutr, Hisashi Okumura, Peter Wolschann, Thanyada Rungrotmongkol. Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptaseJournal of Biomolecular Structure and Dynamics 2021; 39(7): 2502 doi: 10.1080/07391102.2020.1751715
31
Jihye Lim, Jung‐Bok Lee, Jihyun An, Gi‐Won Song, Kang Mo Kim, Han Chu Lee, Ju Hyun Shim. Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome studyJournal of Viral Hepatitis 2022; 29(9): 756 doi: 10.1111/jvh.13721
32
Mei-Juan Peng, Xiao-Qing Guo, Wei-Lu Zhang, Jing Chen, Wen Kang, Xiao-Fei Yang, Ying Guo, Ye Zhang. Effect of pegylated interferon-α2b add-on therapy on renal function in chronic hepatitis B patients: A real-world experienceFrontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.980250
33
Di Liu, Lin Liu, Lizheng Wang, Sizhu Duan, Yanan Song, Meng Qu, Nan Gao, Jiaxin Wu, Haihong Zhang, Hui Wu, Wei Kong, Bin Yu, Xianghui Yu. Therapeutic effects of mesenchymal stem cells combined with short hairpin RNA on liver injury induced by hepatitis B virus infectionMolecular Medicine Reports 2017;  doi: 10.3892/mmr.2017.8096
34
Mariam Nasser Aljaafari, Asma Obaid AlAli, Laila Baqais, Maream Alqubaisy, Mudhi AlAli, Aidin Molouki, Janna Ong-Abdullah, Aisha Abushelaibi, Kok-Song Lai, Swee-Hua Erin Lim. An Overview of the Potential Therapeutic Applications of Essential OilsMolecules 2021; 26(3): 628 doi: 10.3390/molecules26030628
35
Ana Isabel Ribeiro, Alice Maria Dias, Andrea Zille. Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A ReviewACS Applied Nano Materials 2022; 5(3): 3030 doi: 10.1021/acsanm.1c03891
36
Lukas Cerveny, Sara Karbanova, Rona Karahoda, Hana Horackova, Lucie Jiraskova, Mohammed Naji Husaen Ali, Frantisek Staud. Assessment of the role of nucleoside transporters, P-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in the placental transport of entecavir using in vitro, ex vivo, and in situ methodsToxicology and Applied Pharmacology 2023; 463: 116427 doi: 10.1016/j.taap.2023.116427
37
Kerui Xu, Li-Ming Liu, Paraskevi A. Farazi, Hongmei Wang, Fedja A Rochling, Shinobu Watanabe-Galloway, Jian-Jun Zhang. Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis BGlobal Health Action 2018; 11(1): 1433987 doi: 10.1080/16549716.2018.1433987
38
H. J. Tsai, Y. W. Chuang, S. W. Lee, C. Y. Wu, H. Z. Yeh, T. Y. Lee. Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patientsAlimentary Pharmacology & Therapeutics 2018; 47(12): 1673 doi: 10.1111/apt.14682
39
Yu-Ting Zhang, Jing Liu, Xiao-Ben Pan, Yi-Dan Gao, Yin-Fei Hu, Li Lin, Hua-Jun Cheng, Gong-Ying Chen. Successful treatment of infantile hepatitis B with lamivudine: A case reportWorld Journal of Clinical Cases 2021; 9(14): 3442-3448 doi: 10.12998/wjcc.v9.i14.3442
40
Sanjit Boora, Vikrant Sharma, Sulochana Kaushik, Ajoy Varma Bhupatiraju, Sandeep Singh, Samander Kaushik. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problemBrazilian Journal of Microbiology 2023; 54(2): 679 doi: 10.1007/s42770-023-00970-y
41
Idanna Innocenti, Francesca Morelli, Francesco Autore, Andrea Corbingi, Raffaella Pasquale, Federica Sorà, Maurizio Pompili, Luca Laurenti. HBV reactivation in CLL patients with occult HBV infection treated with ibrutinib without viral prophylaxisLeukemia & Lymphoma 2019; 60(5): 1340 doi: 10.1080/10428194.2018.1523401
42
Si-Si Yang, Cheng-Wei Cai, Xue-Qing Ma, Jia Xu, Cheng-Bo Yu. Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysisHepatobiliary & Pancreatic Diseases International 2020; 19(6): 507 doi: 10.1016/j.hbpd.2020.09.007
43
Keping Wu, Xiaochang Xu, Leidan Huang, Enyi Zhu, Yejing Dong, Zhijuan Zhang, Xiuhong Yan, Yimin Zhang. Telbivudine-induced rhabdomyolysis in a patient undergoing haemodialysis: A case report and review of literatureJournal of International Medical Research 2023; 51(12) doi: 10.1177/03000605231222244
44
Vitus Sambo Badii, Kwame Ohene Buabeng, Thomas Agyarko Poku, Arnold Donkor Forkuo, Bright Boafo Boamah, Stephen Mensah Arhin, Daniel Edem Kpewou. Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected AdultsInternational Journal of Chronic Diseases 2018; 2018: 1 doi: 10.1155/2018/3702740